Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 13,800 shares, a decline of 42.5% from the April 30th total of 24,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,800 shares, a drop of 42.5% from the April 30th total of 24,000 shares. Based on an average daily trading volume, of 396,500 shares, the short-interest […]
Contrasting Achilles Therapeutics (NASDAQ:ACHL) & Entera Bio (NASDAQ:ENTX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Achilles Therapeutics (NASDAQ:ACHL – Free Report) had its target price reduced by Chardan Capital from $11.00 to $6.00 in a research report released on Friday, Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Piper Sandler reissued a neutral rating and issued a […]
Achilles Therapeutics (NASDAQ:ACHL) Earns "Neutral" Rating from Piper Sandler themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.